ENDRA Life Sciences Statistics
Total Valuation
NDRA has a market cap or net worth of $5.69 million. The enterprise value is $5.52 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NDRA has 1.24 million shares outstanding. The number of shares has increased by 289.41% in one year.
| Current Share Class | 1.24M |
| Shares Outstanding | 1.24M |
| Shares Change (YoY) | +289.41% |
| Shares Change (QoQ) | +45.88% |
| Owned by Insiders (%) | 5.72% |
| Owned by Institutions (%) | 6.41% |
| Float | 1.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.51 |
| P/TBV Ratio | 2.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.29 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -291.56% and return on invested capital (ROIC) is -122.16%.
| Return on Equity (ROE) | -291.56% |
| Return on Assets (ROA) | -86.73% |
| Return on Invested Capital (ROIC) | -122.16% |
| Return on Capital Employed (ROCE) | -185.74% |
| Weighted Average Cost of Capital (WACC) | 2.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$334,639 |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.83% in the last 52 weeks. The beta is -0.22, so NDRA's price volatility has been lower than the market average.
| Beta (5Y) | -0.22 |
| 52-Week Price Change | +15.83% |
| 50-Day Moving Average | 4.26 |
| 200-Day Moving Average | 4.96 |
| Relative Strength Index (RSI) | 46.95 |
| Average Volume (20 Days) | 20,290 |
Short Selling Information
The latest short interest is 48,279, so 3.89% of the outstanding shares have been sold short.
| Short Interest | 48,279 |
| Short Previous Month | 52,702 |
| Short % of Shares Out | 3.89% |
| Short % of Float | 4.13% |
| Short Ratio (days to cover) | 1.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.76M |
| Pretax Income | -7.03M |
| Net Income | -7.03M |
| EBITDA | -5.72M |
| EBIT | -5.76M |
| Earnings Per Share (EPS) | -$8.93 |
Full Income Statement Balance Sheet
The company has $762,365 in cash and $492,352 in debt, giving a net cash position of $270,013 or $0.22 per share.
| Cash & Cash Equivalents | 762,365 |
| Total Debt | 492,352 |
| Net Cash | 270,013 |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 2.26M |
| Book Value Per Share | 1.92 |
| Working Capital | 217,013 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$5.18 million and capital expenditures -$17,280, giving a free cash flow of -$5.20 million.
| Operating Cash Flow | -5.18M |
| Capital Expenditures | -17,280 |
| Depreciation & Amortization | 44,045 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.20M |
| FCF Per Share | -$4.19 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NDRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -289.41% |
| Shareholder Yield | -289.41% |
| Earnings Yield | -121.28% |
| FCF Yield | -89.74% |
Analyst Forecast
The average price target for NDRA is $30.00, which is 554.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.00 |
| Price Target Difference | 554.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on November 7, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | Nov 7, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |